Aurobindo Pharma`s Generic Flucytosine Receives Approval in US
Hyderabad: Aurobindo Pharma Limited has announced that the Company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Flucytosine Capsules, 250 mg and 500 mg
EMA has recommended that patients should be tested for the lack of the enzyme dihydropyrimidine dehydrogenase (DPD) before starting cancer treatment with fluorouracil given by injection or infusion (drip) or with the related medicines, capecitabine and tegafur.
Recipharm`s Generic Flucytosine Receives Approval In US
MSF to WHO on Updated Guideline: Those Who Need These Medicines Cannot Afford Them
Drug major Lupin on Friday said it has launched Flucytosine capsules, used to treat serious infections, in the American market.
Roxane’s Generic Flucytosine Receives Approval In US
NEW DELHI: Indian pharmaceutical firm LupinBSE 2.96 % Ltd has received final approval from the US Food and Drug Administration (US FDA) to market a generic version of Valeant Pharmaceuticals International Inc’s Ancobon capsules, the company said. The capsules—flucytosine capsules USP (250 mg and 500mg)—are indicated for the treatment of serious infections caused by certain strains of Candida and Cryptococcus, it added.
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.